In a recent interview with Healthcare Brew, Laura Bray discussed how the Iran war could create new vulnerabilities across the global pharmaceutical supply chain, adding pressure to a system already struggling with ongoing drug shortages.
Drug shortages affect real patients every single day—making reliable access to medication not just a goal, but a necessity. That’s why we’re proud to champion the patient voice in three important CMS comment letters focused on strengthening a more dependable and resilient drug supply.
At Angels for Change, advocacy is more than a mission—it’s action. By collaborating with leading partners such as the Duke-Margolis Institute for Health Policy, the End Drug Shortages Alliance (EDSA), and the U.S. Pharmacopeia Drug Shortage Task Force, we’re helping drive solutions that are both practical and firmly rooted in the real needs of patients.
The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.
Angels for Change is proud to announce a major Project PROTECT milestone: our partner Fagron Sterile Services is now fully production-ready with new U.S. capacity for Sterile Water for Injection—a critical component used in countless injectable medicines.
This marks the second successful Project PROTECT collaboration with Fagron, following earlier investments that helped protect patients during the IV fluid shortage in 2024. By investing in domestic manufacturing infrastructure, we’re strengthening the resilience of the U.S. drug supply and protecting patients before shortages occur.
We don’t just talk about ending drug shortages—we’re creating solutions that build onshore readiness, strengthen supply chains, and protect patient access to lifesaving medicines.
Read 2 new warrior stories from patients in a drug shortage crisis and explore how Angels for Change is boldly working with Champions and the Cancer Moonshot team, advocating during a Capitol Hill briefing, expanding of our team to build the supply chain of the future.
Thank you to the Journal of Clinical Pathways for interviewing Chief Change Maker, Laura Bray at the 2024 National Comprehensive Cancer Network annual conference.
Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.
Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization’s 2024 Drug Shortage Guardian Award to Fresenius Kabi (USA), a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition headquartered in Lake Zurich, IL.
SHARE YOUR “WHY”
Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.
